CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
120.4
3.06%
Market Trading Hours* (UTC) Opens on Tuesday at 08:00

Mon - Fri: 08:00 - 16:25

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 1.8
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.021948 %
Charges from full value of position ($-4.17)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.021948%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000275 %
Charges from full value of position ($-0.05)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000275%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency SEK
Margin 5%
Stock exchange Sweden
Commission on trade 0%

*Information provided by Capital.com

Biotage AB ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 124.2
Open* 121.5
1-Year Change* -33.02%
Day's Range* 119 - 124.1
52 wk Range 83.05-199.30
Average Volume (10 days) 188.37K
Average Volume (3 months) 5.14M
Market Cap 10.11B
P/E Ratio 46.26
Shares Outstanding 80.01M
Revenue 1.60B
EPS 2.73
Dividend (Yield %) 1.26683
Beta 1.20
Next Earnings Date Feb 15, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 8, 2023 124.2 3.6 2.99% 120.6 126.8 120.5
Dec 7, 2023 122.8 -0.9 -0.73% 123.7 124.1 119.9
Dec 6, 2023 125.4 3.4 2.79% 122.0 125.5 120.1
Dec 5, 2023 121.1 0.3 0.25% 120.8 122.3 118.7
Dec 4, 2023 121.2 -1.6 -1.30% 122.8 124.7 120.1
Dec 1, 2023 122.8 -2.8 -2.23% 125.6 130.2 122.8
Nov 30, 2023 131.2 3.9 3.06% 127.3 131.2 125.2
Nov 29, 2023 129.4 5.9 4.78% 123.5 129.6 123.5
Nov 28, 2023 126.5 1.8 1.44% 124.7 127.6 122.7
Nov 27, 2023 124.5 -1.3 -1.03% 125.8 127.6 124.0
Nov 24, 2023 128.0 1.7 1.35% 126.3 128.0 124.5
Nov 23, 2023 126.2 0.9 0.72% 125.3 126.6 123.9
Nov 22, 2023 125.4 3.5 2.87% 121.9 126.3 121.9
Nov 21, 2023 121.8 -2.5 -2.01% 124.3 127.1 121.0
Nov 20, 2023 124.4 -2.9 -2.28% 127.3 130.0 123.3
Nov 17, 2023 127.2 9.7 8.26% 117.5 127.4 117.5
Nov 16, 2023 121.3 2.6 2.19% 118.7 121.4 116.5
Nov 15, 2023 118.7 -0.4 -0.34% 119.1 124.3 117.5
Nov 14, 2023 118.7 0.5 0.42% 118.2 121.3 116.6
Nov 13, 2023 118.7 -1.1 -0.92% 119.8 123.4 118.3

Biotage Events

Time (UTC) Country Event
Thursday, February 15, 2024

Time (UTC)

14:00

Country

SE

Event

Q4 2023 Biotage AB Earnings Call
Q4 2023 Biotage AB Earnings Call

Forecast

-

Previous

-
Thursday, April 25, 2024

Time (UTC)

10:59

Country

SE

Event

Q1 2024 Biotage AB Earnings Release
Q1 2024 Biotage AB Earnings Release

Forecast

-

Previous

-
Friday, April 26, 2024

Time (UTC)

15:00

Country

SE

Event

Biotage AB Annual Shareholders Meeting
Biotage AB Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 1566 1232 1092.28 1101.37 910.896
Revenue 1566 1232 1092.28 1101.37 910.896
Cost of Revenue, Total 618 477 425.55 415.963 354.27
Gross Profit 948 755 666.728 685.41 556.626
Total Operating Expense 1239 961 886.093 893.253 738.418
Selling/General/Admin. Expenses, Total 481 374 336.94 360.028 313.127
Research & Development 68 56 44.102 49.733 43.101
Depreciation / Amortization 89 65 66.449 65.132 34.032
Interest Expense (Income) - Net Operating -35 -16 -19.352 -2.41 -14.681
Unusual Expense (Income) 2.5 2.5
Other Operating Expenses, Total 18 5 32.404 2.307 6.069
Operating Income 327 271 206.185 208.12 172.478
Interest Income (Expense), Net Non-Operating -7 -12 -8.901 3.949 3.811
Other, Net 28 10 25.445 -0.077 0
Net Income Before Taxes 348 269 222.729 211.992 176.289
Net Income After Taxes 268 205 175.331 186.82 167.627
Net Income Before Extra. Items 268 205 175.331 186.82 167.627
Net Income 268 205 175.331 186.82 167.627
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items 268 205 175.331 186.82 167.627
Income Available to Common Incl. Extra. Items 268 205 175.331 186.82 167.627
Diluted Net Income 268 205 175.331 186.82 167.627
Diluted Weighted Average Shares 66.1843 65.4648 65.2085 65.1821 64.7144
Diluted EPS Excluding Extraordinary Items 4.0493 3.13145 2.68877 2.86612 2.59026
Dividends per Share - Common Stock Primary Issue 1.6 1.55 1.5 0 1.5
Diluted Normalized EPS 4.29365 3.17802 2.68877 2.89992 2.62699
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 449 409 361 384 401
Revenue 449 409 361 384 401
Cost of Revenue, Total 167 155 141 158 160
Gross Profit 282 254 220 226 241
Total Operating Expense 384 356 307 343 304
Selling/General/Admin. Expenses, Total 169 143 126 150 127
Research & Development 44 37 28 31 28
Other Operating Expenses, Total 3 1 -1 4 -11
Operating Income 65 53 54 41 97
Interest Income (Expense), Net Non-Operating -19 -9 2 55 -12
Net Income Before Taxes 46 44 56 96 85
Net Income After Taxes 38 34 43 74 65
Net Income Before Extra. Items 38 34 43 74 65
Net Income 38 34 43 74 65
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items 38 34 43 74 65
Income Available to Common Incl. Extra. Items 38 34 43 74 65
Diluted Net Income 38 34 43 74 65
Diluted Weighted Average Shares 80.1183 69.5922 66.1808 66.2002 66.1946
Diluted EPS Excluding Extraordinary Items 0.4743 0.48856 0.64974 1.11782 0.98195
Dividends per Share - Common Stock Primary Issue 0 0 0 1.6 0
Diluted Normalized EPS 0.54647 0.76615 0.85858 1.11782 0.98195
Unusual Expense (Income) 1 20 13
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1031 774 751.615 586.569 494.438
Cash and Short Term Investments 441 311 371.325 185.867 177.02
Cash & Equivalents 441 311 371.325 185.867 177.02
Total Receivables, Net 260 207 207.455 212.815 173.728
Accounts Receivable - Trade, Net 223 180 194.018 197.651 156.042
Total Inventory 305 237 159.823 173.76 132.338
Prepaid Expenses 25 19 13.013 14.128 11.352
Other Current Assets, Total -0.001 -0.001
Total Assets 2339 1992 1434.44 1335.69 1003.2
Property/Plant/Equipment, Total - Net 162 128 103.656 112.253 48.63
Property/Plant/Equipment, Total - Gross 385 324 201.79 215.717 130.51
Accumulated Depreciation, Total -223 -196 -98.134 -103.464 -81.88
Goodwill, Net 794 741 290.209 315.869 186.055
Intangibles, Net 308 313 250.787 260.047 192.654
Long Term Investments 21 14 12.254 16.614 17.368
Note Receivable - Long Term 0.003
Other Long Term Assets, Total 23 22 25.92 44.335 64.055
Total Current Liabilities 417 313 217.364 212.272 173.397
Accounts Payable 57 56 51.236 41.461 54.764
Payable/Accrued 0.001
Accrued Expenses 58.479 69.334 60.411
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 25 23 21.214 21.231
Other Current Liabilities, Total 335 234 86.435 80.245 58.222
Total Liabilities 702 621 444.403 460.184 301.023
Total Long Term Debt 192 180 140.677 147.647 109.4
Deferred Income Tax 71 73 32.838 28.884 14.78
Other Liabilities, Total 22 55 53.524 71.381 3.446
Total Equity 1637 1371 990.038 875.503 702.18
Common Stock 93 92 90.969 90.63 89.953
Retained Earnings (Accumulated Deficit) 1229 1063 956.114 781.121 692.104
Other Equity, Total 34 -50 -116.547 3.752 -79.877
Total Liabilities & Shareholders’ Equity 2339 1992 1434.44 1335.69 1003.2
Total Common Shares Outstanding 65.9838 65.9838 65.2018 64.7144 64.7144
Long Term Debt 150 150 110 109.55 109.4
Capital Lease Obligations 42 30 30.677 38.097
Additional Paid-In Capital 281 266 59.502
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 1379 1288 1034 1031 1008
Cash and Short Term Investments 501 444 426 441 388
Cash & Equivalents 501 444 426 441 388
Total Receivables, Net 370 408 306 285 314
Accounts Receivable - Trade, Net 279 308 229 223 253
Total Inventory 508 436 302 305 306
Other Current Assets, Total
Total Assets 5001 5002 2362 2339 2306
Property/Plant/Equipment, Total - Net 193 200 98 162 138
Goodwill, Net 2491 2575 801 794 804
Intangibles, Net 888 885 376 308 319
Long Term Investments 19 20 20 21 15
Other Long Term Assets, Total 31 34 33 23 22
Total Current Liabilities 728 689 377 417 402
Accounts Payable 174 139 64 57 74
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 30 22 23 25 23
Other Current Liabilities, Total 524 528 290 335 305
Total Liabilities 1311 1257 674 702 707
Total Long Term Debt 221 196 196 192 174
Long Term Debt 150 150 150 150 150
Capital Lease Obligations 71 46 46 42 24
Deferred Income Tax 202 212 86 71 73
Other Liabilities, Total 160 160 15 22 58
Total Equity 3690 3745 1688 1637 1599
Common Stock 112 112 93 93 92
Additional Paid-In Capital 2291 2289 282 281 277
Retained Earnings (Accumulated Deficit) 1241 1199 1273 1229 1155
Other Equity, Total 46 145 40 34 75
Total Liabilities & Shareholders’ Equity 5001 5002 2362 2339 2306
Total Common Shares Outstanding 80.0082 79.9379 65.9838 65.9838 65.9838
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 348 269 222.729 211.992 176.289
Cash From Operating Activities 341 353 279.047 211.807 155.005
Cash From Operating Activities 102 75 73.904 74.372 39.412
Non-Cash Items -17 4 -11.661 2.129 -11.727
Cash Taxes Paid 52 16 15.083 9.925 9.314
Cash Interest Paid 5 3 3.339 2.86 1.738
Changes in Working Capital -92 5 -5.925 -76.686 -48.969
Cash From Investing Activities -84 -341 -61.32 -85.676 -178.411
Capital Expenditures -70 -56 -60.941 -45.454 -47.158
Other Investing Cash Flow Items, Total -14 -285 -0.379 -40.222 -131.253
Cash From Financing Activities -133 -82 -22.723 -119.205 19.342
Total Cash Dividends Paid -102 -98 0 -97.803 -90.6
Issuance (Retirement) of Debt, Net -30 16 -22.723 -21.402 109.942
Foreign Exchange Effects 7 9 -9.547 1.921 6.821
Net Change in Cash 131 -61 185.457 8.847 2.757
Financing Cash Flow Items -1
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 56 348 252 167 92
Cash From Operating Activities 11 341 242 145 57
Cash From Operating Activities 26 102 74 49 23
Non-Cash Items -3 -17 28 23 5
Cash Taxes Paid 39 52 38 27 15
Changes in Working Capital -68 -92 -112 -94 -63
Cash From Investing Activities -19 -84 -49 -32 -14
Capital Expenditures -19 -70 -49 -31 -14
Other Investing Cash Flow Items, Total 0 -14 0 -1 0
Cash From Financing Activities -7 -133 -127 -119 -6
Issuance (Retirement) of Debt, Net -7 -30 -25 -17 -6
Foreign Exchange Effects 0 7 12 8 2
Net Change in Cash -15 131 78 2 39
Total Cash Dividends Paid 0 -102 -102 -102 0
Financing Cash Flow Items -1
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Kohlberg Kravis Roberts & Co. L.P. Private Equity 16.85 13481379 13481379 2023-08-31 MED
SEB Investment Management AB Investment Advisor 7.19 5752589 190157 2023-08-31 LOW
Didner & Gerge Fonder AB Investment Advisor 5.1902 4152571 150000 2023-10-17 LOW
Invesco Advisers, Inc. Investment Advisor 4.31 3448353 -32099 2023-08-31 LOW
Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 4.22 3376345 -23874 2023-08-31 LOW
ODIN Forvaltning AS Investment Advisor 3.7496 3000000 0 2023-09-30 LOW
Fjärde AP-Fonden Pension Fund 3.37 2696276 10736 2023-08-31 LOW
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 3.2497 2600000 0 2023-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.96 2368242 39015 2023-08-31 LOW
Lannebo Fonder AB Investment Advisor/Hedge Fund 2.7053 2164438 0 2022-12-31 LOW
Första AP-Fonden Pension Fund 2.36 1888193 559480 2023-08-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.14 1712175 154251 2023-08-31 LOW
Danske Bank Asset Management Investment Advisor 1.5507 1240672 30000 2023-09-30 LOW
TIN Fonder Investment Advisor 1.4 1120115 100151 2023-08-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.39 1112114 -62397 2023-08-31 LOW
Tredje AP Fonden Pension Fund 1.2969 1037604 -1033099 2023-06-30 MED
Montanaro Asset Management Limited Investment Advisor 1.22 976100 72122 2023-08-31 LOW
M&G Investment Management Ltd. Investment Advisor 1.2 960098 75915 2023-08-31 LOW
Andra AP-Fonden Pension Fund 1.02 816083 -160477 2023-08-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1 800082 28072 2023-08-31 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Biotage Company profile

Biotage is a Sweden-based Life Science company, specialising in separation and synthesis solutions. The company’s offering comprises three distinct product lines. The Organic Chemistry line seeks to rationalise the development of drugs by purifying substances that will become new drugs. The Analytical Chemistry line aims to reinvent the sample analysis. The Industrial Product line offers innovative systems and consumables that separate substances during the large-scale production. All product lines are available across Europe and the US by the Biotage sales organisation or by distributors. Headquartered in Uppsala, Sweden, Biotage trades on the NASDAQ Stockholm under the BIOT ticker. Find out the latest BIOT stock news at Capital.com.
Industry: Medical Diagnostic & Testing Equipment

Vimpelgatan 5
UPPSALA
UPPSALA 753 18
SE

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

US100

16,219.10 Price
+0.880% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

1,981.42 Price
-1.180% 1D Chg, %
Long position overnight fee -0.0201%
Short position overnight fee 0.0118%
Overnight fee time 22:00 (UTC)
Spread 0.50

BTC/USD

40,845.85 Price
-6.830% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

XRP/USD

0.62 Price
-7.230% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading